A collection of stock notes from around the web.
June 18, 2008
Good News for Exelixis
Exelixis recently received approval for one of its drugs to enter into a Phase 3 trial. In this post, the Motley Fool disclosed that they own shares of the company.
Post a Comment
Post Comments (Atom)